J 2024

Technology-assisted cardiac rehabilitation for coronary heart disease patients with central obesity a randomized controlled trial

SU, Jing-Jing, Arkers-Kwan-Ching WONG, Li-Ping ZHANG, Jonanthan BAYUO, Rose S LIN et. al.

Basic information

Original name

Technology-assisted cardiac rehabilitation for coronary heart disease patients with central obesity a randomized controlled trial

Authors

SU, Jing-Jing, Arkers-Kwan-Ching WONG, Li-Ping ZHANG, Jonanthan BAYUO, Rose S LIN, Hammoda ABU-ODAH and Ladislav BAŤALÍK (203 Czech Republic, belonging to the institution)

Edition

EUROPEAN JOURNAL OF PHYSICAL AND REHABILITATION MEDICINE, TURIN, EDIZIONI MINERVA MEDICA, 2024, 1973-9087

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Italy

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.500 in 2022

Organization unit

Faculty of Medicine

DOI

UT WoS

001146141900001

Keywords in English

Cardiac rehabilitation; Coronary disease; Obesity; Technology; Randomized controlled trial

Tags

Tags

International impact, Reviewed
Změněno: 10/6/2024 13:04, Mgr. Tereza Miškechová

Abstract

V originále

BACKGROUND: Limited empirical evidence is available regarding the effect of technology-assisted cardiac rehabilitation (TACR) among coronary heart disease (CHD) patients with central obesity. AIM: To determine the effects of 12-week TACR on health outcomes of patients with CHD.DESIGN: Two-arm randomized controlled trial.SETTING: Cardiovascular department of a regional hospital.POPULATION: Coronary heart disease patients with central obesity.METHODS: The study randomized 78 hospitalized CHD patients to receive either the 12-week TACR intervention or usual care. Guided by social cognitive theory, the intervention began with an in-person assessment and orientation session to assess and identify individual risks and familiarize with the e-platform/device before discharge. After discharge, patients were encouraged to visit the interactive CR website for knowl-edge and skills acquisition, data uploading, use the pedometer for daily step tracking, and interact with peers and professionals via social media for problem-solving and mutual support. Data were collected at baseline (T0), six-week (T1), and 12-week (T2).RESULTS: Participants in the intervention group showed significant improvement in daily steps at six weeks but not 12 weeks (T1: beta=2713.48, P=0.03; T2:beta=2450.70, P=0.08), weekly sitting minutes (T1: beta=-665.17, P=0.002; T2: beta=-722.29, P=0.02), and total (vigorous, moderate, and walking) exercise at 12-week (beta=-2445.99, P=0.008). Improvement in health-promoting lifestyle profile (T1: beta=24.9, P<0.001; T2: beta=15.50, P<0.001), smoking cessation (T2: beta=-2.28, P<0.04), self-efficacy (T2: beta=0.63, P=0.02), body mass index (T1:beta =-0.97, P=0.03; T2: beta=-0.73, P=0.04) and waist circumferences (T1: beta =-1.97, P=0.003; T2: beta =-3.14, P=0.002) were identified.CONCLUSIONS: Results indicated the effectiveness of the TACR intervention in improving healthy behaviors and anthropometric parameters for CHD patients with central obesity. Individual assessment, collaborative action planning, and ongoing obesity management support should be highlighted in TACR programs for CHD patients.CLINICAL REHABILITATION IMPACT: Central obesity should be assessed and highlighted in TACR intervention as an independent risk factor that requires corresponding behavior change and body fat management.